Survodutide, Boehringer Ingelheim's GLP-1/glucagon dual, reached Phase 3 with placebo-adjusted weight-loss and MASH-resolution data that validated the mechanism
FDA Warning: RISK OF THYROID C-CELL TUMORS Other GLP-1 agonists been found to cause a dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice
Its a quick process, but following each step is important for safe and effective results
Common contributors include sleep disorders, chronic stress, hormonal imbalances (particularly thyroid dysfunction), nutritional deficiencies (such as vitamin B12 or iron), autoimmune conditions (like multiple sclerosis or lupus), medications, and metabolic disorders including diabetes
By boosting telomerase, Epithalon may slow this process, supporting healthier, longer-living cells Beyond telomere support, Epithalon acts as an antioxidant, protecting cells from damage over time